Drug Shortage Report for CLAVULIN 400

Last updated on 2020-06-03 History
Report ID 110855
Drug Identification Number 02238830
Brand name CLAVULIN 400
Common or Proper name amoxicillin / clavulanate potassium for oral suspension
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) CLAVULANIC ACID AMOXICILLIN
Strength(s) 57MG 400MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 70mL
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-01
Estimated end date Unknown
Actual end date 2020-06-01
Shortage status Resolved
Updated date 2020-06-03
Company comments Re-supply is ongoing with inventory allocated to 100% of regular demand.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-06-03 French Compare
v5 2020-06-03 English Compare
v4 2020-05-01 French Compare
v3 2020-05-01 English Compare
v2 2020-04-03 French Compare
v1 2020-04-03 English Compare